Strength
8 mg/1
Manufacturer
AvPAKNDC
50268070815
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RAMELTEONApproval Type
Generic (ANDA)
FDA Application
ANDA091693On Market Since
1/6/2021
Pharmacological Classes
Price Statistics
The NADAC for RAMELTEON 8 MG TABLET has been published 259 times since Jul 14, 2021, and over the history we have for it it has declined 72.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6898 per EA |
|---|---|
| All-time high | $2.4714 (Jul 14, 2021) |
| All-time low | $0.5491 (Nov 20, 2024) |
| 52-week high | $0.8071 |
| 52-week low | $0.6898 |
| Median price | $0.9135 |
| Average price | $0.9642 |
| Largest weekly change | +50.1% (Aug 21, 2024) |
| Weeks tracked | 259 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RAMELTEON 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RAMELTEON 8 MG TABLET, manufactured by AvPAK, is $0.6898 per EA (NDC 50268070815), effective Jun 24, 2026.
How has the price of RAMELTEON 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for RAMELTEON 8 MG TABLET has declined 72.1%. It has been tracked across 259 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for RAMELTEON 8 MG TABLET?
Since Jul 14, 2021, the NADAC for RAMELTEON 8 MG TABLET has ranged from a low of $0.5491 (Nov 20, 2024) to a high of $2.4714 (Jul 14, 2021), with a median of $0.9135 per EA.
Are there cheaper alternatives to RAMELTEON 8 MG TABLET?
11 NADAC-published products share the same active ingredient, strength, and dosage form as RAMELTEON 8 MG TABLET, but none are currently priced below it.
Who manufactures RAMELTEON 8 MG TABLET?
RAMELTEON 8 MG TABLET (NDC 50268070815) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification